CD8A and cancer: While there is much to learn about the role of TREM2 in cancer, some key studies indicate that TREM2 is involved in suppressing the function of CD8+ T cells as well as inhibiting their proliferation, which would argue for myeloid-targeted inhibition of TREM2 at least in some cancers.